Calcium, bioenergetics, and neuronal vulnerability in Parkinson's disease
- PMID: 23086948
- PMCID: PMC3624453
- DOI: 10.1074/jbc.R112.410530
Calcium, bioenergetics, and neuronal vulnerability in Parkinson's disease
Abstract
The most distinguishing feature of neurons is their capacity for regenerative electrical activity. This activity imposes a significant mitochondrial burden, especially in neurons that are autonomously active, have broad action potentials, and exhibit prominent Ca(2+) entry. Many of the genetic mutations and toxins associated with Parkinson's disease compromise mitochondrial function, providing a mechanistic explanation for the pattern of neuronal pathology in this disease. Because much of the neuronal mitochondrial burden can be traced to L-type voltage-dependent channels (channels for which there are brain-penetrant antagonists approved for human use), a neuroprotective strategy to reduce this burden is available.
References
-
- Braak H., Ghebremedhin E., Rüb U., Bratzke H., Del Tredici K. (2004) Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res. 318, 121–134 - PubMed
-
- Augustine G. J., Santamaria F., Tanaka K. (2003) Local calcium signaling in neurons. Neuron 40, 331–346 - PubMed
-
- Clapham D. E. (2007) Calcium signaling. Cell 131, 1047–1058 - PubMed
-
- Decuypere J.-P., Bultynck G., Parys J. B. (2011) A dual role for Ca2+ in autophagy regulation. Cell Calcium 50, 242–250 - PubMed
-
- Lloyd-Evans E., Platt F. M. (2011) Lysosomal Ca2+ homeostasis: role in pathogenesis of lysosomal storage diseases. Cell Calcium 50, 200–205 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous